MX2020004877A - Dispositivos y metodos para perforar una capsula para liberar un medicamento en polvo a partir de la misma. - Google Patents

Dispositivos y metodos para perforar una capsula para liberar un medicamento en polvo a partir de la misma.

Info

Publication number
MX2020004877A
MX2020004877A MX2020004877A MX2020004877A MX2020004877A MX 2020004877 A MX2020004877 A MX 2020004877A MX 2020004877 A MX2020004877 A MX 2020004877A MX 2020004877 A MX2020004877 A MX 2020004877A MX 2020004877 A MX2020004877 A MX 2020004877A
Authority
MX
Mexico
Prior art keywords
capsule
puncturing
release
powdered medicament
methods
Prior art date
Application number
MX2020004877A
Other languages
English (en)
Inventor
Colleen Ellwanger
Brian Noble
Tim Coker
Sean Plunkett
Original Assignee
Civitas Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50824204&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2020004877(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Civitas Therapeutics Inc filed Critical Civitas Therapeutics Inc
Publication of MX2020004877A publication Critical patent/MX2020004877A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A61M15/0035—Piercing means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A61M15/0041—Details of the piercing or cutting means with movable piercing or cutting means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

Un dispositivo (100) para perforar una cápsula (219) para liberar un medicamento en polvo a partir de la misma incluye una cámara (210) para recibir la cápsula. La cápsula incluye domos opuestos y una porción de la pared cilíndrica definida por un radio r de la pared de la cápsula. El dispositivo además incluye un mecanismo (230) para perforar al menos un agujero en al menos un domo. Un centro de cada agujero está localizado dentro de la región de perforación anular situada a no menos de un 0.4 r, y un área de superficie total de todos los agujeros perforados es de entre aproximadamente 0.5% y aproximadamente 2.2% del área de superficie total de la cápsula. La región de perforación anular puede, por ejemplo, estar situada entre aproximadamente 0.4 r y aproximadamente 0.8 r, o entre aproximadamente 0.4 r y aproximadamente 0.6 r.
MX2020004877A 2012-12-04 2015-06-04 Dispositivos y metodos para perforar una capsula para liberar un medicamento en polvo a partir de la misma. MX2020004877A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261733117P 2012-12-04 2012-12-04
US13/719,598 US20140150787A1 (en) 2012-12-04 2012-12-19 Devices and methods for puncturing a capsule to release a powdered medicament therefrom

Publications (1)

Publication Number Publication Date
MX2020004877A true MX2020004877A (es) 2020-08-13

Family

ID=50824204

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2015007115A MX2015007115A (es) 2012-12-04 2013-12-03 Dispositivos y metodos para perforar una capsula para liberar un medicamento en polvo a partir de la misma.
MX2020004877A MX2020004877A (es) 2012-12-04 2015-06-04 Dispositivos y metodos para perforar una capsula para liberar un medicamento en polvo a partir de la misma.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2015007115A MX2015007115A (es) 2012-12-04 2013-12-03 Dispositivos y metodos para perforar una capsula para liberar un medicamento en polvo a partir de la misma.

Country Status (19)

Country Link
US (4) US20140150787A1 (es)
EP (3) EP3607986A3 (es)
JP (5) JP2015536765A (es)
KR (2) KR102248068B1 (es)
CN (1) CN104981264B (es)
AU (5) AU2013356299B2 (es)
BR (1) BR112015013017B1 (es)
CA (2) CA3209510A1 (es)
DK (1) DK3090773T3 (es)
ES (1) ES2760606T3 (es)
FR (1) FR20C1011I1 (es)
HK (1) HK1226012A1 (es)
MX (2) MX2015007115A (es)
NZ (1) NZ708449A (es)
PL (1) PL3090773T3 (es)
PT (1) PT3090773T (es)
RU (1) RU2677766C2 (es)
SG (1) SG11201504387UA (es)
WO (1) WO2014089018A2 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150080786A1 (en) * 2013-09-16 2015-03-19 Robert E. King Compact Consciousness Arousing Device
US10238820B2 (en) 2014-01-08 2019-03-26 Seroton, Inc. Dry-powder inhalation device
US11491288B2 (en) 2014-01-08 2022-11-08 Seroton, Inc. Dispenser for dry-powder inhalation devices
USD755367S1 (en) 2014-03-10 2016-05-03 Civitas Therapeutics, Inc. Indicator for an inhaler
USD752204S1 (en) 2014-03-10 2016-03-22 Civitas Therapeutics, Inc. Indicator for an inhaler
USD752734S1 (en) * 2014-03-10 2016-03-29 Civitas Therapeutics, Inc. Inhaler grip
AU2017369978A1 (en) * 2016-11-30 2019-04-11 Philip Morris Products S.A. Inhaler with sized cavity
CN106542161B (zh) * 2017-01-19 2018-04-20 朱兴春 一种收集胶囊药物的方法
JP2020527377A (ja) * 2017-06-28 2020-09-10 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム 吸入器と併用するための粒子を含む容器
DE102018108958A1 (de) * 2018-04-16 2019-10-17 Emphasys Importadora Exportadora E Distribuidora Ltda. Trockenpulverinhalator

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1182779A (en) * 1966-09-17 1970-03-04 Fisons Pharmaceuticals Ltd Inhalation Device
US4069819A (en) * 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
US3927195A (en) * 1974-01-31 1975-12-16 Lilly Industries Ltd Production of capsules
IT1228460B (it) * 1989-02-23 1991-06-19 Phidea S R L Inalatore monouso con capsula pre-forata
DE69133562D1 (de) * 1990-10-31 2007-04-12 Monodor Sa Vorrichtung und kartusche zum bereiten eines flüssigen produkts
ES2181935T3 (es) 1991-05-31 2003-03-01 Scherer Technologies Inc R P Metodo y aparato para fabricar capsulas farmaceuticas de celulosa- dimensionamiento la capsula.
PT101450B (pt) * 1994-02-02 1999-11-30 Hovione Produtos Farmaceuticos Novo dispositivo para inalacao
US5897880A (en) * 1995-09-29 1999-04-27 Lam Pharmaceuticals, Llc. Topical drug preparations
US6063405A (en) * 1995-09-29 2000-05-16 L.A.M. Pharmaceuticals, Llc Sustained release delivery system
DE69825879T2 (de) * 1997-02-21 2005-09-01 Targacept, Inc. Pharmazeutische zusammensetzungen welche aryl-substituierte olefinische amin-verbindungen enthalten
PT998271E (pt) * 1997-06-06 2005-10-31 Depomed Inc Formas de dosagem oral de farmacos com retencao gastrica para a libertacao controlada de farmacos altamente soluveis
US6766799B2 (en) 2001-04-16 2004-07-27 Advanced Inhalation Research, Inc. Inhalation device
ITMI20020078A1 (it) * 2002-01-16 2003-07-16 Fabrizio Niccolai Dispositivo utilizzabile nel tratamento di affezzioni delle vie respiratorie
DK1531798T3 (da) 2002-03-20 2012-08-13 Civitas Therapeutics Inc Pulmonal frigørelse af Levodopa
PT1485154E (pt) * 2002-03-20 2008-06-17 Alkermes Inc Dispositivo de inalação de pó
US20040206350A1 (en) * 2002-12-19 2004-10-21 Nektar Therapeutics Aerosolization apparatus with non-circular aerosolization chamber
US20050081852A1 (en) * 2002-12-30 2005-04-21 Nektar Therapeutics (Formely Inhale Therapeutic System Inc.) Package for an aerosolization apparatus and pharmaceutical formulation receptacle
US20050056280A1 (en) * 2002-12-31 2005-03-17 Nektar Therapeutics Receptacle for an aerosolizable pharmaceutical formulation
US7878193B2 (en) 2003-01-14 2011-02-01 Boehringer Ingelheim International Gmbh Capsule for taking an active substance which can be inhaled
ES2310722T3 (es) * 2003-03-20 2009-01-16 Galephar M/F Sistema inhalador de polvo seco mejorado.
US7954491B2 (en) * 2003-06-13 2011-06-07 Civitas Therapeutics, Inc. Low dose pharmaceutical powders for inhalations
ATE347837T1 (de) * 2004-10-25 2007-01-15 Nestec Sa Kapsel mit dichtungsmitteln
RU2369411C2 (ru) * 2005-04-21 2009-10-10 Бёрингер Ингельхайм Интернациональ Гмбх Порошковый ингалятор
US8360057B2 (en) * 2006-03-10 2013-01-29 Dose One, Llc Medication inhaler for dispensing multiple capsules
WO2008156586A2 (en) * 2007-06-12 2008-12-24 Alkermes, Inc. Inhalation device for powdered substances
CN101888867B (zh) * 2007-12-05 2013-05-15 诺瓦提斯公司 用于可雾化的药物制剂的容器
KR101569604B1 (ko) * 2007-12-28 2015-11-16 임팩스 라보라토리즈, 인코포레이티드 레보도파 방출 제어형 제제 및 이의 용도
EP2082768A1 (en) * 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
MY169949A (en) * 2009-08-28 2019-06-19 Keurig Green Mountain Inc Beverage cartridge and method for beverage formation using filter aid
JP7236257B2 (ja) * 2018-11-30 2023-03-09 三星電子株式会社 衣類乾燥機

Also Published As

Publication number Publication date
CN104981264A (zh) 2015-10-14
AU2020250224B2 (en) 2022-02-03
AU2019204497A1 (en) 2019-07-11
NZ708449A (en) 2019-09-27
BR112015013017A2 (pt) 2017-07-11
JP2022133450A (ja) 2022-09-13
AU2022202802B2 (en) 2024-02-15
WO2014089018A2 (en) 2014-06-12
AU2019204497B2 (en) 2020-07-16
RU2015126657A (ru) 2017-01-13
EP3090773A3 (en) 2017-02-08
JP2024057017A (ja) 2024-04-23
CN104981264B (zh) 2018-04-03
ES2760606T3 (es) 2020-05-14
AU2018204682A1 (en) 2018-07-19
RU2677766C2 (ru) 2019-01-21
JP2020127773A (ja) 2020-08-27
KR20150100712A (ko) 2015-09-02
CA2894031A1 (en) 2014-06-12
EP2928530A2 (en) 2015-10-14
AU2013356299A1 (en) 2015-06-11
PT3090773T (pt) 2020-01-06
EP3090773B1 (en) 2019-09-18
AU2018204682B2 (en) 2019-04-11
FR20C1011I1 (fr) 2020-05-01
EP3607986A2 (en) 2020-02-12
BR112015013017B1 (pt) 2022-06-21
MX2015007115A (es) 2016-03-31
JP2018118062A (ja) 2018-08-02
KR20210049984A (ko) 2021-05-06
KR102248068B1 (ko) 2021-05-04
DK3090773T3 (da) 2019-12-09
PL3090773T3 (pl) 2020-05-18
JP2015536765A (ja) 2015-12-24
SG11201504387UA (en) 2015-07-30
EP3090773A2 (en) 2016-11-09
HK1226012A1 (zh) 2017-09-22
CA3209510A1 (en) 2014-06-12
EP3607986A3 (en) 2020-07-15
US20140150787A1 (en) 2014-06-05
US20240198020A1 (en) 2024-06-20
WO2014089018A3 (en) 2014-08-07
US20180289904A1 (en) 2018-10-11
KR102416895B1 (ko) 2022-07-05
AU2022202802A1 (en) 2022-05-19
CA2894031C (en) 2023-10-03
AU2013356299B2 (en) 2018-04-19
US20210244895A1 (en) 2021-08-12
AU2020250224A1 (en) 2020-11-05

Similar Documents

Publication Publication Date Title
MX2020004877A (es) Dispositivos y metodos para perforar una capsula para liberar un medicamento en polvo a partir de la misma.
TW201613906A (en) Amorphous body of tetracyclic compound
MY185623A (en) Aerosol provision system
WO2013163598A3 (en) Reconstitution device
MX2015005238A (es) Unidad de empaque de un producto farmacuetico, medico o cosmetico y un metodo de esterilizacion de un producto farmaceutico, medico o cosmetico que se puede colocar en la unidad de empaque.
CA2905350A1 (en) Capsule with messaging system
EP2836306A4 (en) SPRAYJECTOR MECHANISMS AND DEVICES WITH LOAD INSULATION AND CONTROLLABLE DROUGHT LOADING, AND OPHTHALMIC ADMINISTRATION WITH LOW DOSAGE VOLUME
WO2013020123A3 (en) Surgical devices and methods providing sacroiliac stabilization
BR112017006965A2 (pt) unidade de infusão para um dispositivo de produção de bebida, e, dispositivo de produção de bebida
GB2561994A (en) Open-top microfluidic devices and methods for simulating a function of a tissue
CA2927311C (en) Inflatable exercise chamber
MX2015008069A (es) Conjunto de envasado para dispositivos de administracion de farmacos.
GB2542731A (en) Foam pressure sensor
WO2013135494A3 (en) Lithographic apparatus
EP3573616A4 (en) NEW INHIBITOR OF SPIRO AND CYCLIC BIS-BENZYLIDINE PROTEASOME FOR THE TREATMENT OF CANCER, DIABETES AND NEUROLOGICAL DISORDERS
MY189897A (en) Vacuum insulation body
MX363699B (es) Producto de comicronizacion que comprende acetato de ulipristal.
MX346656B (es) Artículo absorbente que tiene un conjunto absorbente con aletas de contención integrales.
PH12017500581A1 (en) Breakable capsule for smoking article
MY182988A (en) Container with spout and manufacturing method thereof
WO2012024461A3 (en) Intravaginal devices, methods of making, and uses thereof
WO2012105797A3 (ko) 나노 안테나를 포함하는 구조체 및 이의 제조방법
Mueller Mueller AM, Rosso C, Entezari V, McKenzie B, Hasebroock A, Della Croce U, Nazarian A, Ramappa AJ, DeAngelis JP. The effect of supraspinatus tears on glenohumeral translations in passive pitching motion. Am J Sports Med. 2014; 42 (10): 2455-2462.(Original DOI: 10.1177/0363546514547348)
CN103800197A (zh) 安全精密用药器具
张静 A Critique of Irony Study